Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract

The effects of standardized aqueous mistletoe extracts on Health Related Quality of Life (HRQoL) of tumor patients needs further evaluation. In this non-interventional, prospective clinical investigation the longitudinal course of Quality of Life of 270 breast cancer patients during adjuvant chemoth...

Full description

Saved in:
Bibliographic Details
Published in:Phytomedicine (Stuttgart) 2011-01, Vol.18 (2-3), p.151-157
Main Authors: Eisenbraun, J., Scheer, R., Kröz, M., Schad, F., Huber, R.
Format: Article
Language:English
Subjects:
AbnobaVISCUM
Adolescent
Adult
Aged
Antineoplastic Agents - adverse effects
Breast cancer
Breast Neoplasms - drug therapy
Breast Neoplasms - surgery
Cancer
Care and treatment
Chemical properties
Chemotherapy
Chemotherapy, Adjuvant
Complementary
Diagnosis
Female
Health aspects
Health Related Quality of Life
Humans
Longitudinal Studies
Management
Materia medica, Vegetable
Middle Aged
Mistletoe
Phytotherapy
Plant extracts
Plant Extracts - therapeutic use
Prospective Studies
QLQ-C30
Quality of Life
Social aspects
Surveys and Questionnaires
Tolerability
Viscum album
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The effects of standardized aqueous mistletoe extracts on Health Related Quality of Life (HRQoL) of tumor patients needs further evaluation. In this non-interventional, prospective clinical investigation the longitudinal course of Quality of Life of 270 breast cancer patients during adjuvant chemotherapy and mistletoe therapy with abnobaVISCUM® Mali was investigated. HRQoL was measured 4 times by self-assessment with the QLQ-C30 and QLQ-BR23 questionnaire of the European Organization for Research and Treatment of Cancer (EORTC): at the beginning of mistletoe- and chemotherapy, 4 weeks later, at the end of the chemotherapy and 4 weeks after finishing chemotherapy. Secondary objectives were the tolerability and safety of mistletoe therapy in combination with chemotherapy under conditions of daily practice. After an initial deterioration the average range of all obtained QLQ-C30 function scales (n=262, 48.9–71.5) remained stable even at the last chemotherapy cycle and improved significantly (p
ISSN:0944-7113
1618-095X
DOI:10.1016/j.phymed.2010.06.013